Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RARRES3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HRASLS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LGALS12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLA2G16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HRASLS5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RTN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on